In patients with rheumatoid arthritis and preserved kidney function, reduced initial doses of JAK inhibitors show 2-year treatment persistence and disease control similar to those with standard doses.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/reduced-jak-inhibitor-dosing-may-not-compromise-ra-outcomes-2026a1000gyv?src=rss
Author :
Publish date : 2026-05-25 07:17:00
Copyright for syndicated content belongs to the linked Source.
